Verve Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2020
Period Ending	Aug '25 Aug 7, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2019 - 2020
Market Capitalization	1,629	1,689	182	132	-	-	Upgrade
Market Cap Growth	168.49%	825.73%	38.70%	-	-	-	Upgrade
Enterprise Value	1,518	1,651	107	35	-	-	Upgrade
Last Close Price	4.38	5.42	0.70	0.51	-	-	Upgrade
PS Ratio	151.16	146.79	18.62	20.37	-	-	Upgrade
PB Ratio	12.79	11.55	2.64	1.43	-	-	Upgrade
P/TBV Ratio	12.79	11.55	2.64	1.43	-	-	Upgrade
EV/Sales Ratio	140.84	143.49	10.87	5.40	-	-	Upgrade
Asset Turnover	0.11	0.10	0.11	0.11	0.20	0.29	Upgrade
Quick Ratio	13.74	18.44	9.95	13.19	9.91	9.43	Upgrade
Current Ratio	14.55	19.05	10.17	13.26	10.00	9.56	Upgrade
Return on Equity (ROE)	-53.99%	-39.28%	-30.48%	-42.23%	-71.89%	-80.00%	Upgrade
Return on Assets (ROA)	-36.11%	-24.19%	-18.65%	-17.41%	-40.63%	-45.29%	Upgrade
Return on Capital (ROIC)	-39.07%	-25.99%	-20.42%	-18.94%	-45.34%	-50.74%	Upgrade
Earnings Yield	-2.99%	-2.51%	-13.48%	-18.06%	-	-	Upgrade
FCF Yield	-2.89%	-2.59%	-15.10%	-10.28%	-	-	Upgrade
Buyback Yield / Dilution	-15.21%	-5.22%	-4.81%	-40.37%	-20.54%	-2.86%	Upgrade

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.